Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: July 29, 2004
Reporting Period: Second Quarter of 2004
This filing serves as a notification of the company's financial results for the second quarter of 2004. The report incorporates by reference a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) regarding the period's earnings.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references the existence of financial results but does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached exhibits (99.1 and 99.2), which are not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only indicates that results for the second quarter of 2004 have been reported.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, contingencies, or descriptions of unusual items. These disclosures are presumed to be within the referenced press release and supplemental information exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2004 revenue and net income figures.
- Examine Exhibit 99.2 for supplemental data not included in the main press release.
- Verify year-over-year growth rates and margin trends in the full earnings release.
- Check for any updated full-year guidance or strategic initiatives mentioned in the referenced documents.